Ascendent Capital Partners Ii Gp Limited - Net Worth and Insider Trading
Ascendent Capital Partners Ii Gp Limited Net Worth
The estimated net worth of Ascendent Capital Partners Ii Gp Limited is at least $604 Million dollars as of 2025-01-09. Ascendent Capital Partners Ii Gp Limited is the 2201 Interest of corporation controlled by you of SciClone Pharmaceuticals (Holdings) Ltd and owns about 32,259,037 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) stock worth over $604 Million. Details can be seen in Ascendent Capital Partners Ii Gp Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ascendent Capital Partners Ii Gp Limited has not made any transactions after 2023-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ascendent Capital Partners Ii Gp Limited
Ascendent Capital Partners Ii Gp Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ascendent Capital Partners Ii Gp Limited owns 1 companies in total, including SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) .
Insider Ownership Summary of Ascendent Capital Partners Ii Gp Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06600 | SciClone Pharmaceuticals (Holdings) Ltd | 2023-12-07 | 2201 Interest of corporation controlled by you |
Ascendent Capital Partners Ii Gp Limited Latest Holdings Summary
Ascendent Capital Partners Ii Gp Limited currently owns a total of 1 stock. Ascendent Capital Partners Ii Gp Limited owns 32,259,037 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) as of December 7, 2023, with a value of $604 Million.
Latest Holdings of Ascendent Capital Partners Ii Gp Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06600 | SciClone Pharmaceuticals (Holdings) Ltd | 2023-12-07 | 32,259,037 | 18.72 | 603,889,173 |
Holding Weightings of Ascendent Capital Partners Ii Gp Limited
Ascendent Capital Partners Ii Gp Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Ascendent Capital Partners Ii Gp Limited has made a total of 4 transactions in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in SciClone Pharmaceuticals (Holdings) Ltd is the sale of 29,600,000 shares on December 7, 2023, which brought Ascendent Capital Partners Ii Gp Limited around $0.
Insider Trading History of Ascendent Capital Partners Ii Gp Limited
- 1
Ascendent Capital Partners Ii Gp Limited Trading Performance
Ascendent Capital Partners Ii Gp Limited Ownership Network
Ascendent Capital Partners Ii Gp Limited Owned Company Details
What does SciClone Pharmaceuticals (Holdings) Ltd do?
Who are the key executives at SciClone Pharmaceuticals (Holdings) Ltd?
Ascendent Capital Partners Ii Gp Limited is the 2201 Interest of corporation controlled by you of SciClone Pharmaceuticals (Holdings) Ltd. Other key executives at SciClone Pharmaceuticals (Holdings) Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2101 Beneficial owner Zhao Hong , and Gl Capital Management Gp Limited .
SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) Insider Trades Summary
Over the past 18 months, Ascendent Capital Partners Ii Gp Limited made 2 insider transaction in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) with a net sale of 0. Other recent insider transactions involving SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) include a net purchase of 354,500 shares made by UBS Group AG , a net sale of 0 shares made by Zhao Hong , and a net sale of 0 shares made by Ascendent Silver (cayman) Limited .
In summary, during the past 3 months, insiders sold 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) were sold and 354,500 shares were bought by its insiders, resulting in a net purchase of 354,500 shares.
SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600)'s detailed insider trading history can be found in Insider Trading Tracker table.
SciClone Pharmaceuticals (Holdings) Ltd Insider Transactions
Ascendent Capital Partners Ii Gp Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Ascendent Capital Partners Ii Gp Limited. Currently GuruFocus does not have mailing address information for Ascendent Capital Partners Ii Gp Limited.
Discussions on Ascendent Capital Partners Ii Gp Limited
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
